Skip to main content

UBS Group AG

Position in WAT — Waters Corp /De/

CIK 1610520 ZURICH, V8

Position in WAT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$190,692,952
+$55,490,566 QoQ
Shares Held
640,339
+79.9% QoQ
Ownership
0.652%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 93.79125744332299.ToString("F0")% Shared 0.ToString("F0")% None 6.20874255667701.ToString("F0")%

Common Shares in WAT Over Time

Shares Held

Position Value (USD)

Derivatives in WAT

reported options exposure · as of Jun 30, 2020
CallValue
$0
CallShares
0
PutValue
$234,520
PutShares
1,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,686,317,391 across 46 Diagnostics & Research names. WAT ranks #3 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 WAT
Waters Corp /De/
This page
640,339 $190,692,952

All Filings in WAT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $190,692,952 640,339
2025-12-31 $135,202,386 355,955
2025-09-30 $61,416,975 204,853
2025-06-30 $73,639,061 210,976
2025-03-31 $67,737,635 183,785
2024-12-31 $53,005,248 142,879
2024-09-30 $38,542,056 107,094
2024-06-30 $33,406,445 115,147
2024-03-31 $35,815,064 104,044
2023-12-31 $4,270,440 12,971
2023-09-30 $3,823,857 13,945
2023-06-30 $14,494,443 54,380
2023-03-31 $4,977,920 16,077
2022-12-31 $15,222,884 44,436
2022-09-30 $4,676,344 17,350
2022-06-30 $5,313,220 16,053
2022-03-31 $5,967,246 19,225
2021-12-31 $21,698,732 58,236
2021-09-30 $16,786,667 46,982
2021-06-30 $28,567,775 82,659
2021-03-31 $29,697,184 104,505
2020-12-31 $27,550,957 111,353
2020-09-30 $12,631,534 64,552
2020-06-30 $234,520 1,300
2020-06-30 $10,916,544 60,513
2020-03-31 $9,694,889 53,254